Jeonjinbio Co., Ltd. (KOSDAQ:110020)

Jeonjinbio Revenue

Jeonjinbio had revenue of 2.88B KRW in the quarter ending March 31, 2026, with 33.68% growth. This brings the company's revenue in the last twelve months to 14.42B, down -15.28% year-over-year. In the year 2025, Jeonjinbio had annual revenue of 13.69B, down -28.94%.

• Revenue (ttm): 14.42B
• Revenue Growth: -15.28%
• P/S Ratio: 1.11
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 15.94B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	13.69B	-5.58B	-28.94%
Dec 31, 2024	19.27B	3.59B	22.91%
Dec 31, 2023	15.68B	7.89B	101.18%
Dec 31, 2022	7.79B	4.58B	142.48%
Dec 31, 2021	3.21B	-652.23M	-16.87%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 1, 2026

Data Sources Report a data error